[Federal Register Volume 68, Number 44 (Thursday, March 6, 2003)]
[Notices]
[Page 10739]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-5234]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as 
amended. The contract proposals and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the contract proposals, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, In Vitro Antiviral Screening 
Program PART A: Human Papilloma Virus.
    Date: March 21, 2003.
    Time: 10 a.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Health/NIAID, Fernwood Building, 
10401 Fernwood Building, 2C-07, Bethesda, MD 20892. (Telephone 
conference call.)
    Contact Person: Vassil St. Georgiev, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, Room 2102, 6700-B Rockledge Drive, MSC 
7610, Bethesda, MD 20892-7610. 301-496-2550. [email protected].


(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbilogy and Infectious Diseases Research, National Institutes of 
Health, HHS)
    Dated: February 25, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-5234 Filed 3-3-03; 8:45 am]
BILLING CODE 4140-01-M